Table 2.
Baseline characteristics of healthcare providers
Provider Characteristics | Total (N=45) |
---|---|
Age, years | |
Mean (SD) | 44 (13.3) |
Gender, N (%) | |
Male | 12 (27) |
Female | 33 (73) |
Race/ethnicity, N (%) | |
Non-Hispanic White | 31 (69) |
Non-Hispanic Black | 4 (9) |
Hispanic | 4 (9) |
Asian | 5 (11) |
Other Race | 1 (2) |
Medical specialty, N (%) | |
Internal medicine | 30 (67) |
Family medicine | 4 (9) |
Gynecology | 6 (13) |
Other | 5 (11) |
Number of years since completed training, N (%) | |
Have not yet finished training | 10 (22) |
<5 | 8 (18) |
5-10 | 6 (13) |
11-15 | 4 (9) |
16-20 | 8 (18) |
>20 | 9 (20) |
Willingness to try new technology (range, 0-100) | |
Mean (SD) | 78.2 (19.6) |
Number of years using EHR, N (%) | |
<5 | 8 (18) |
5-10 | 25 (56) |
11-15 | 10 (22) |
16-20 | 2 (4) |
Ever used the Gail model, N (%) | |
Yes | 20 (44) |
Used the Gail model for which patients (multiple responses) | |
Women age 60 years or older | 4 (20) |
Women with a breast cancer family history | 10 (50) |
Women who may be at higher than average risk for breast cancer | 10 (50) |
I do not regularly use breast cancer risk assessment tools | 7 (35) |
No | 25 (56) |
Reasons for not using the Gail model (multiple responses) | |
I do not see patients in whom breast cancer risk calculation is indicated | 1 (4) |
I do not have enough time with my patients to use breast cancer risk assessment tools | 6 (24) |
I do not think that the results of breast cancer risk assessment tools would change my management | 4 (16) |
I am not sufficiently familiar with breast cancer risk assessment tools | 20 (80) |
Ever prescribed chemoprevention, N (%) | |
Yes | 11 (24) |
About how many patients | |
1-5 | 11 (100) |
No | 33 (73) |
Reasons for not prescribing chemoprevention (multiple responses) | |
I have not identified a patient in whom chemoprevention was indicated | 8 (24) |
I do not believe that chemoprevention benefits most women who are eligible to receive it | 0 |
I am not comfortable prescribing chemoprevention | 18 (55) |
I do not have time to discuss chemoprevention with my patients | 4 (12) |
I would prefer to refer my high-risk patients to a specialist to discuss chemoprevention | 22 (66) |
Mean confidence in risk communication [range, 1 - 6] (SD) | 3.80 (0.10) |